InnovAge Holding (INNV) Stock Forecast: StockMap's 2-Week Call
INNV stock forecast: StockMap's model leans Underperform on InnovAge Holding for the two weeks after the Nov 19 close, toward INNV trailing the growth index. It is a lean inside the no-call band, not a call, and not a price target. Right in 2 of 5 two-week windows on INNV since Aug 21; by chance, a call on the same dates was right 61% of the time.
InnovAge Holding last closed at $8.91, +0.00% on the session.
Against the IVW growth benchmark the position is +2.33% over the forecast window.
InnovAge Holding's market cap is $1.22B as of November 19, 2026.
Leans down ↘: a small lean, not a call · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -33 (too close to call).
Where INNV sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 3 bullish and 12 bearish.
Agreement across those insights is 80%.
21 daily calls for INNV so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks InnovAge Holding in the 3rd percentile on valuation and the 45th percentile on return on equity, where 100 is best.
InnovAge Holding is classified under Health Care / Health Care Providers & Services.
StockMap tracks InnovAge Holding as the 54th largest of the 87 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.
Across that group the current two-week reads are 52 Neutral, 18 Moderate Underperform, 12 Moderate Outperform and 5 Strong Underperform.
On that composite InnovAge Holding ranks 76th of 87 in the group, against a group median of -0.06.